Humana CMO Shantanu Nundy Receives 2,549-Share Award

What Happened
Shantanu Nundy, Chief Medical Officer of Humana Inc. (HUM), received an award of 2,549 restricted stock units (RSUs) on 2026-09-01. The filing reports an acquisition of 2,549 shares at $0.00 (total reported value $0) under the company’s 2026 Stock Incentive Plan. This is a grant/award transaction (code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-01 (Form 4 filed 2026-09-03). No late filing indicated in the provided data.
• Reported amount and price: 2,549 RSUs @ $0.00 (reported value $0).
• Shares owned after the transaction: Not stated in the provided filing excerpt.
• Footnote: These 2,549 RSUs represent a contingent right to receive one share each and are exempt under Rule 16b-3(d)(1) & (3) per the Company’s 2026 Stock Incentive Plan (footnote F1).
• Transaction type: Award/grant (code A); not a sale, purchase, or option exercise.

Context
RSU grants are a common form of executive compensation and represent a future right to receive shares if vesting conditions are met; they do not require cash outlay by the insider at grant (hence $0 reported). Such awards are not necessarily an immediate signal of bullish or bearish insider sentiment—they reflect compensation decisions and plan rules. The filing notes the exemption under Rule 16b-3, which is typical for employer grants to executives.